Intelligence · Patents
Patents expiring in 2028
Annual patent cliff calendar for 2028 — US pharmaceutical patents by expiration date.
- Patents
- 624
Quick answer
624 indexed pharmaceutical patents have expiration dates in 2028. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7381748
Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase
granted -
US 7381827
Processes and intermediates
granted -
US 7381404
Treatment for dry macular degeneration
granted -
US 7381699
Reagents and methods for smooth muscle therapies
granted -
US 7381825
Histone deacetylase inhibitors
granted -
US 7381744
Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds
granted -
US 7381405
Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer
granted -
US 7381408
Methods for chemically synthesizing immunoglobulin chimeric proteins
granted -
EP 1926473
ANTIMIKROBIELLE ZUBEREITUNGEN MIT EINEM IN LIPOSOMEN VERKAPSELTEN GEHALT AN OCTENIDINDIHYDROCHLORID
granted -
US 7384978
Compounds and methods for delivery of prostacyclin analogs
granted -
US 7384909
Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
granted -
US 7384921
Polymorphic forms of 6-11 bicyclic ketolide derivatives
granted -
US 7384623
High energy phototherapeutic agents
granted -
US 7388079
Delivery of pharmaceutical agents via the human insulin receptor
granted -
US 7388089
Anti-arthropod vector vaccines method of selecting and uses thereof
granted -
US 7388074
Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
granted -
US 7387896
MicroRNA vectors
granted -
US 7388071
Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response
granted -
US 7388002
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
granted -
US 7388032
Sustained release compositions, process for producing the same and utilization thereof
granted -
US 7387881
Detection and treatment of cancers of the liver
granted -
US 7388017
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
granted -
US 7388088
High affinity human antibodies to tumor antigens
granted -
US 7387792
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
granted -
AU 2007332640
Powder formulation for valganciclovir
granted -
US 7390625
Apoptosis-associated protein and use thereof
granted -
US 7390646
Bacterial vectors and methods of use thereof
granted -
US 7390808
Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
granted -
US 7390510
Preparation of hypericin bonded with poly-N-vinylamides
granted -
US 7390668
Intracorporeal medicaments for photodynamic treatment of disease
granted -
US 7390807
Crystal forms of lamotrigine and processes for their preparations
granted -
US 7390815
Pyrazole compounds useful as protein kinase inhibitors
granted -
US 7390813
Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
granted -
CA 2673419
COMPOSITION PHARMACEUTIQUE
granted -
CA 2673418
COMPOSE ET COMPOSITION PHARMACEUTIQUES
granted -
CA 2670932
DETECTION DU DETACHEMENT D'UN AGENT DE CONTRASTE IMMOBILISE DANS DES APPLICATIONS D'IMAGERIE MEDICALE
granted -
US 7393994
Transgenic mouse model for neurodegenerative diseases
granted -
US 7393544
Dispersion for pulmonary delivery of a bioactive agent
granted -
US 7393842
Pyrazole analogs acting on cannabinoid receptors
granted -
US 7393855
2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrimidines as antiviral agents
granted -
US 7393833
Chimeric proteins with phosphatidylserine binding domains
granted -
EP 1938801
Nanoemulsion
granted -
US 7396839
Crystalline forms of gatifloxacin
granted -
US 7396816
Low-molecular weight peptides inhibiting ion channel activity
granted -
US 7396848
Neurotrophin production/secretion promoting agent
granted -
US 7396933
Quinolinone-carboxamide compounds
granted -
US 7396841
Injections
granted -
US 7396927
Process for preparation of rosuvastatin calcium
granted
Frequently asked questions
How many pharma patents expire in 2028?
624 published patents in our USPTO index have expiration dates falling in calendar year 2028.